67.00
+5.00
(8.06%)
Real-time:
8:06am BST
LON real-time data - Disclaimer
Currency in GBX unless noted
| Range | - |
| 52 week | 44.30 - 348.00 |
| Open | 62.00 |
| Vol. | 0.00 |
| Mkt cap | 3.24M* |
| P/E | - |
| Div/yield | - |
| EPS | -0.24* |
| Shares | 4.83M |
| Beta | - |
| Inst. own | - |
| *GBP |
Key stats and ratios
| Q3 (Sep '12) | 2012 | |
| Net profit margin | -183.58% | 1.13% |
| Operating margin | -183.70% | 0.75% |
| EBITD margin | - | 21.83% |
| Return on average assets | -60.72% | 0.97% |
| Return on average equity | -69.09% | 1.13% |
| Employees | 25 | - |
| Carbon Disclosure Rating | - | - |
Address
Level Two Springfield House, 23 Oatlands Drive 81-83 Victoria Road, Surbiton
WEYBRIDGE, SCO KT13 9LZ
United Kingdom - Map
+44-1932-252123 (Phone)
+44-1932-251113 (Fax)
WEYBRIDGE, SCO KT13 9LZ
United Kingdom - Map
+44-1932-252123 (Phone)
+44-1932-251113 (Fax)
Website links
External links
Analyst Estimates - BusinessWeek
Options - MarketWatch
Research Reports - Reuters
Director Dealings - Yahoo Finance
Discussion Group - Google Finance
Advertisement
Description
AorTech International plc is a holding company. The Company is engaged in the development and exploitation of a range of biomaterials and medical devices. The Company�s segments are based on geographical location of operations, which includes United Kingdom, Australia and United States. The Company�s polymer technology includes Elast-Eon, ECSil and E- RIM. AorTech is based in Rogers, Minnesota, where its principal manufacturing and research and development facility is located. The Company�s subsidiaries include AorTech Biomaterials Limited, AorTech Critical Care Limited, AorTech Heart Valve Technologies Limited, AorTech Biomaterials Pty Limited AorTech Polymers & Medical Devices, Inc. and River Clyde Marine, Inc.
Officers and directors
| Frank Maguire | Chief Executive, Executive Director | |
| Edward McDaid | Finance Director, Executive Director | |
| J. C. David Parsons | Company Secretary | |
| William Donald Brown | Non-Executive Chairman of the Board | |
| Gordon Wright | Non-Executive Director |